Advertisement

Amphiphilically modified chitosan cationic nanoparticles for drug delivery

  • Jie You
  • Wenfeng Li
  • Chang Yu
  • Chengguang Zhao
  • Langping Jin
  • Yili Zhou
  • Xuzhong Xu
  • Siyang Dong
  • Xincheng Lu
  • Ouchen Wang
Research Paper

Abstract

A series of amphiphilic N-(2-hydroxy)propyl-3-trimethylammonium-chitosan-cholic acid (HPTA-CHI-CA) polymers were synthesized by grafting cholic acid (CA) and glycidyltrimethylammonium chloride onto chitosan. The self-assembly behavior of HPTA-CHI-CA was studied by fluorescence technique. The polymers were able to self-assemble into NPs in phosphate buffered saline with a critical aggregation concentration (CAC) in the range of 66–26 mg/L and the CAC decreased with the increasing of the degree of substitution (DS) of CA. The size of cationic HPTA-CHI-CA NPs ranges from 170 to 220 nm (PDI < 0.2). It was found that doxorubicin (DOX) could be encapsulated into HPTA-CHI-CA NPs based on self-assembly. The drug loading content and efficiency varies depending on the DS of CA and feeding ratio of DOX to polymer. In vitro release studies suggested that DOX released slowly from HPTA-CHI-CA NPs without any burst initial release. Besides, the confocal microscopic measurements indicated that DOX-HPTA-CHI-CA NPs could easily be uptaken by breast cancer (MCF-7) cells and release DOX in cytoplasm. Anti-tumor efficacy results showed that DOX-HPTA-CHI-CA NPs have a significant activity of inhibition MCF-7 cells growth. These results suggest cationic HPTA-CHI-CA may have great potential for anticancer drug delivery.

Keywords

Chitosan Cationic nanoparticles Doxorubicin Cellular uptake Drug delivery 

Notes

Acknowledgments

This work was supported by National Natural Science Foundation of China Grant 81072405, Zhejiang Provincial Natural Science Foundation Grants R2100528 and LY12H31003, and Zhejiang Provincial Program for the Cultivation of High level Innovative Health talents and for Innovative Research Team in Zhejiang Province Grant 2010R50046.

Supplementary material

11051_2013_2123_MOESM1_ESM.docx (224 kb)
Supplementary material 1 (DOCX 224 kb)

References

  1. Boddohi S, Moore N, Johnson PA, Kipper MJ (2009) Polysaccharide-based polyelectrolyte complex nanoparticles from chitosan, heparin, and hyaluronan. Biomacromolecules 10:1402–1409CrossRefGoogle Scholar
  2. Guo S, Qiao Y, Wang W, He H, Deng L, Xing J, Xu J, Liang XJ, Dong A (2010) Poly(ε-caprolactone)-graft-poly(2-(N,N-dimethylamino) ethyl methacrylate) nanoparticles: pH dependent thermo-sensitive multifunctional carriers for gene and drug delivery. J Mater Chem 20:6935–6941CrossRefGoogle Scholar
  3. Huang CK, Lo CL, Chen HH, Hsiue GH (2007) Multifunctional micelles for cancer cell targeting, distribution imaging, and anticancer drug delivery. Adv Funct Mater 17:2291–2297CrossRefGoogle Scholar
  4. Kamaly N, Xiao Z, Valencia PM, Radovic-Moreno AF, Farokhzad OC (2012) Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chem Soc Rev 41:2971–3010CrossRefGoogle Scholar
  5. Kumar M, Muzzarelli RAA, Muzzarelli C, Sashiwa H, Domb AJ (2004) Chitosan chemistry and pharmaceutical perspectives. Chem Rev 104:6017–6084CrossRefGoogle Scholar
  6. Lee KY, Kwon IC, Kim YH, Jo WH, Jeong SY (1998) Preparation of chitosan self-aggregates as a gene delivery system. J Control Release 51:213–220CrossRefGoogle Scholar
  7. Lee ALZ, Wang Y, Cheng HY, Pervaiz S, Yang YY (2009) The co-delivery of paclitaxel and herceptin using cationic micellar nanoparticles. Biomaterials 30:919–927CrossRefGoogle Scholar
  8. Li T, Longobardi L, Granero-Molto F, Myers TJ, Yan Y, Spagnoli A (2010) Use of glycol chitosan modified by 5β-cholanic acid nanoparticles for the sustained release of proteins during murine embryonic limb skeletogenesis. J Control Release 144:101–108CrossRefGoogle Scholar
  9. Liu XM, Yang YY, Leong KW (2003) Thermally responsive polymeric micellar nanoparticles self-assembled from cholesteryl end-capped random poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide): synthesis, temperature sensitivity, and morphologies. J Colloid Interface Sci 266:295–303CrossRefGoogle Scholar
  10. Liu SQ, Tong YW, Yang YY (2005) Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(d,l-lactide-co-glycolide) with varying compositions. Biomaterials 26:5064–5074CrossRefGoogle Scholar
  11. Liu F, Feng L, Zhang L, Zhang X, Zhang N (2013) Synthesis, characterization and antitumor evaluation of CMCS-DTX conjugates as novel delivery platform for docetaxel. Int J Pharm 451:41–49CrossRefGoogle Scholar
  12. Mao SR, Sun W, Kissel T (2010) Chitosan-based formulations for delivery of DNA and siRNA. Adv Drug Deliv Rev 62:12–27CrossRefGoogle Scholar
  13. Min KH, Park K, Kim YS, Bae SM, Lee S, Jo HG, Park RW, Kim IS, Jeong SY, Kim K, Kwon IC (2008) Hydrophobically modified glycol chitosan nanoparticles- encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy. J Control Release 127:208–218CrossRefGoogle Scholar
  14. Oh NM, Oh KT, Baik HJ, Lee BR, Lee AH, Youn YS, Lee ES (2010) A self-organized 3-diethylaminopropyl-bearing glycol chitosan nanogel for tumor acidic pH targeting: in vitro evaluation. Colloids Surf B Biointerfaces 78:120–126CrossRefGoogle Scholar
  15. Pan Z, Gao Y, Heng L, Liu Y, Yao G, Wang Y, Liu Y (2013) Amphiphilic N-(2,3-dihydroxypropyl)-chitosan-cholic acid micelles for paclitaxel delivery. Carbohydr Polym 94:394–399CrossRefGoogle Scholar
  16. Peer D, Karp JM, Hong S, FaroKhzad OC, Margalit R, Langer R (2007) Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2:751–760CrossRefGoogle Scholar
  17. Qiu LY, Bae YH (2007) Self-assembled polyethylenimine-graft- poly(epsilon-caprolactone) micelles as potential dual carriers of genes and anticancer drugs. Biomaterials 28:4132–4142CrossRefGoogle Scholar
  18. Termsarasab U, Cho HJ, Kim DH, Chong S, Chung SJ, Shim CK, Moon HT, Kim DD (2013) Chitosan oligosaccharide-arachidic acid-based nanoparticles for anti-cancer drug delivery. Int J Pharm 441:373–380CrossRefGoogle Scholar
  19. Tian HY, Deng C, Lin H, Sun JR, Deng MX, Chen XS, Jing XB (2005) Biodegradable cationic PEG-PEI-PBLG hyperbranched block copolymer: synthesis and micelle characterization. Biomaterials 26:4209–4217CrossRefGoogle Scholar
  20. Tseng YC, Mozumdar S, Huang L (2009) Lipid-based systemic delivery of siRNA. Adv Drug Deliv Rev 61:721–731CrossRefGoogle Scholar
  21. Van Vlerken LE, Amiji MM (2006) Multi-functional polymeric nanoparticles for tumour-targeted drug delivery. Expert Opin Drug Deliv 3:205–216CrossRefGoogle Scholar
  22. Wang Y, Gao SJ, Ye WH, Yoon HS, Yang YY (2006) Co-delivery of drugs and DNA from cationic core-shell nanoparticles self-assembled from a biodegradable copolymer. Nat Mater 5:791–796CrossRefGoogle Scholar
  23. Wang XY, Zhang L, Wei XH, Wang Q (2013) Molecular dynamics of paclitaxel encapsulated by salicylic acid-grafted chitosan oligosaccharide aggregates. Biomaterials 34:1843–1851CrossRefGoogle Scholar
  24. Xiong XB, Uludag H, Lavasanifar A (2009) Biodegradable amphiphilic poly(ethylene oxide)-block-polyesters with grafted polyamines as supramolecular nanocarriers for efficient siRNA delivery. Biomaterials 30:242–253CrossRefGoogle Scholar
  25. Zhang C, Qu GW, Sun YJ, Wu XJ, Yao ZL, Guo QL, Ding QO, Yuan ST, Shen ZL, Ping QE, Zhou HP (2008) Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel. Biomaterials 29:1233–1241CrossRefGoogle Scholar
  26. Zhang A, Zhang Z, Shi F, Ding J, Xiao C, Zhuang X, He C, Chen L, Chen X (2013a) Disulfide crosslinked PEGylated starch micelles as efficient intracellular drug delivery platforms. Soft Matter 9:2224–2233CrossRefGoogle Scholar
  27. Zhang L, Yao J, Zhou J, Wang T, Zhang Q (2013b) Glycyrrhetinic acid-graft-hyaluronic acid conjugate as a carrier for synergistic targeted delivery of antitumor drugs. Int J Pharm 441:654–664CrossRefGoogle Scholar
  28. Zhao SH, Wu XT, Guo WC, Du YM, Yu L, Tang J (2010) N-(2-hydroxyl) propyl-3-trimethyl ammonium chitosan chloride nanoparticle as a novel delivery system for parathyroid hormone-related protein 1-34. Int J Pharm 393:269–273CrossRefGoogle Scholar
  29. Zhou C, Gao W, Lu G, Ding J, Wu X, Huang X, Chen J, Liu M, Jiang J, Wu H (2013) Preparation, characterization and in vitro release of microparticles based on dextran-rosuvastatin conjugate. Carbohydr Polym 96:156–162CrossRefGoogle Scholar
  30. Zhu JL, Cheng H, Jin Y, Cheng SX, Zhang XZ, Zhuo RX (2008) Novel polycationic micelles for drug delivery and gene transfer. J Mater Chem 18:4433–4441CrossRefGoogle Scholar
  31. Zhu CH, Jung S, Luo SB, Meng FH, Zhu XL, Park TG, Zhong ZY (2010) Co-delivery of siRNA and paclitaxel into cancer cells by biodegradable cationic micelles based on PDMAEMA-PCL-PDMAEMA triblock copolymers. Biomaterials 31:2408–2416CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2013

Authors and Affiliations

  • Jie You
    • 1
  • Wenfeng Li
    • 2
  • Chang Yu
    • 1
  • Chengguang Zhao
    • 3
  • Langping Jin
    • 1
  • Yili Zhou
    • 1
  • Xuzhong Xu
    • 1
  • Siyang Dong
    • 1
  • Xincheng Lu
    • 4
  • Ouchen Wang
    • 1
  1. 1.Department of OncologyThe First Affiliated Hospital of Wenzhou Medical CollegeWenzhouChina
  2. 2.Department of Radiotherapy and ChemotherapyThe First Affiliated Hospital of Wenzhou Medical CollegeWenzhouChina
  3. 3.Department of PharmacyWenzhou Medical CollegeWenzhouChina
  4. 4.Institute of Genomic MedicineWenzhou Medical CollegeWenzhouChina

Personalised recommendations